Ausgabe 4/2017
Inhalt (12 Artikel)
5T4 oncofoetal antigen: an attractive target for immune intervention in cancer
- Review
Peter L. Stern, Richard Harrop
Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer
- Open Access
- Original Article
Renate Pichler, Georg Gruenbacher, Zoran Culig, Andrea Brunner, Dietmar Fuchs, Josef Fritz, Hubert Gander, Andrea Rahm, Martin Thurnher
Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma—safety and efficacy in a phase II study
- Original Article
Benjamin Weide, Alexander Martens, Kilian Wistuba-Hamprecht, Henning Zelba, Ludwig Maier, Hans-Peter Lipp, Bernhard D. Klumpp, Daniel Soffel, Thomas K. Eigentler, Claus Garbe
Delivery of foreign cytotoxic T lymphocyte epitopes to tumor tissues for effective antitumor immunotherapy against pre-established solid tumors in mice
- Original Article
Herbert W. Kavunja, Shuyao Lang, Suttipun Sungsuwan, Zhaojun Yin, Xuefei Huang
The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients
- Original Article
Ana Colado, María Belén Almejún, Enrique Podaza, Denise Risnik, Carmen Stanganelli, Esteban Enrique Elías, Patricia Dos Santos, Irma Slavutsky, Horacio Fernández Grecco, María Cabrejo, Raimundo Fernando Bezares, Mirta Giordano, Romina Gamberale, Mercedes Borge
Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma
- Original Article
Cheng Chen, Kesang Li, Hua Jiang, Fei Song, Huiping Gao, Xiaorong Pan, Bizhi Shi, Yanyu Bi, Huamao Wang, Hongyang Wang, Zonghai Li
Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model
- Original Article
Joanne Leung, Philippe St-Onge, John Stagg, Woong-Kyung Suh
Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients
- Original Article
Kimberly R. Jordan, Puja Kapoor, Eric Spongberg, Richard P. Tobin, Dexiang Gao, Virginia F. Borges, Martin D. McCarter
Inclusion of BLIMP-1+ effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: a pilot study
- Original Article
Kirsten A. Ward-Hartstonge, John L. McCall, Timothy R. McCulloch, Ann-Kristin Kamps, Adam Girardin, Erika Cretney, Fran M. Munro, Roslyn A. Kemp
Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α
- Original Article
Genevieve Hartley, Daniel Regan, Amanda Guth, Steven Dow
Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D
- Original Article
Zhongjuan Wang, Linghua Guo, Yuan Song, Yinsheng Zhang, Dandan Lin, Bo Hu, Yu Mei, Dedy Sandikin, Haiyan Liu
In memory of Professor Enrico Mihich: Editor-in-Chief of Cancer Immunology, Immunotherapy 1982–2012
- Obituary
Graham Pawelec, Suzanne Ostrand-Rosenberg
